. "0"^^ . . "Latent' toxoplasmic infection in an HIV+ patient represents a possible precursor condition to toxoplasmic encephalitis. Prevalence in the HIV+ and HIV- populations is apparently the same although in HIV+ men it is unusually elevated. Toxoplasma gondii infection, albeit without symptoms of clinical toxoplasmosis, could affect the progression of HIV infection. This may manifest by a decrease in CD4+ T lymphocyte counts and lowered life expectancy for the patient. Answers to a number of questions associated with the risks of toxoplasmosis in HIV+ patients may be found by analysis of the unique data collected by the AIDS Centre and NRL for Toxoplasmosis who have monitored HIV+ patients since 1988."@en . "1"^^ . "TOXOPLASMOSIS AND ASSOCIATED RISKS IN HIV POSITIVE PATIENTS: A COHORT STUDY 1988 - 2007"@en . . "2007-12-31+01:00"^^ . . . . "\"\"\"Latentn\u00ED\"\" toxoplasmov\u00E1 infekce p\u0159edstavuje pro HIV+ pacienta riziko jako mo\u017En\u00FD p\u0159edstupe\u0148 toxoplasmick\u00E9 encefalitis. C\u00EDlem pr\u00E1ce je popsat p\u0159\u00EDpadn\u00E9 rozd\u00EDly v prevalenci toxoplasm\u00F3zy HIV+ a HIV- populace.. Infekce Toxoplasma gondii, by\u0165 i bez p\u0159\u00EDznak\u016F klinick\u00E9 toxoplasm\u00F3zy, by mohla ovlivnit progresi infekce HIV, co\u017E se m\u016F\u017Ee projevit nap\u0159\u00EDklad sni\u017Eov\u00E1n\u00EDm po\u010Dtu CD4+ T lymfocyt\u016F a zkr\u00E1cen\u00EDm doby p\u0159e\u017E\u00EDv\u00E1n\u00ED pacienta. Odpov\u011Bdi na celou \u0159adu ot\u00E1zek spojen\u00FDch s riziky vyvolan\u00FDmi toxoplasm\u00F3zou lze z\u00EDskat anal\u00FDzou jedine\u010Dn\u00FDch dat, kter\u00E1 z\u00EDskalo AIDS centrum a NRL pro toxoplasm\u00F3zu monitorov\u00E1n\u00EDm HIV+ osob od roku 1988.\""@cs . "Toxoplasm\u00F3za u HIV positivn\u00EDch pacient\u016F a rizika s n\u00ED spojen\u00E1: kohortov\u00E1 studie 1988-2007"@cs . "Toxoplasmosis; encephalitis; HIV; HAART; CD4+; incidence; prevalence; mortality"@en . "2005-01-01+01:00"^^ . . . . "1"^^ . "6"^^ . "6"^^ . . "1335"^^ . "2035"^^ .